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The action of adrenergic drugs on Sprague-Dawley rat spleen
lymphocyte proliferation in the absence and presence of mitogens
was studied by in vitro 3H-thymidine incorporation. When the
incubation was carried out at 37 °C for 48 hours followed by 6
hours pulse labelling with 3H-thymidine, optimal incorporation of
the radiolabel can be obtained using 3 x 105 cells per well in
the presence of either 1 ug/ml concanavalin A (con A) or 10 ug/ml
1ipopolysaccbaride (LPS) or 106 cells per well in the absence of
mi togens.
The adrenergic drugs used included isoproterenol,
norepinephrine and epinephrine. They were found to exert an
inhibitory effect on the basal, con A-induced and
LPS-induced 3H-thymidine incorporation. The IC50 were in the
range of 10 uM to 100 uM. The specific binding of 3H-DHA (1 nM)
was estimated to be 2 fmole/106 cells, supporting the existence
of beta adrenergic receptors on rat spleen lymphocytes. However,
no alpha1 and alpha2 adrenergic receptors could be detected by
radioreceptor assays using 3H-WB41O1 and 3H-para-aminoclonidine
as the respective radioligands. Furthermore, isoproterenol (1
uM) was able to stimulate cAMP accumulation in rat spleen
lymphocytes from less than 1 pmole/106 cells to more than 6
pmoles/106 cells.
4Dibutyryl cAMP which micmicked the action of cAMP and
phosphodiesterase inhibitors including theophylline and isobutyl
methylxanthine (IBMX) were able to suppress the basal, the con A-
induced and LPS-induced 3H-thymidine incorporation with IC50
ranging from 30 to 500 uM.
A23187, a calcium ionophore, exerted a biphasic action on
the 3H-thymidine incorporation in rat spleen lymphocytes. The
optimal concentration for stimulation was cell concentration
dependent, being 1 uM at 3 x 105 cells per well and 300 nM at
106 cells per well.
Phorbol myristate acetate (PMA), an activator of protein
kinase C, was found to stimulate the basal 3H-thymidine
incorporation dose-dependently (0.1- 1.0 ug/ml). Moreover, a
biphasic action was observed on the LPS-induced 3H-thymidine
incorporation. The optimal stimulation occurred at 10 ng/ml PMA.
On the other hand, it inhibited the con A-induced response. A
synergistic action was also observed in the presence of 10 ng/ml
PMA and 10 ug/ml LPS.
In the presence of PMA, dibutyryl cAMP (100 uM),
theophylline (1 mM) and IBMX (100 uM) were still able to inhibit
the basal, the con A-induced and the LPS-induced 3H-thymidine
incorporation. However, the three adrenergic drugs (100 uM) could
only inhibit the basal and the LPS-induced but not the con A-
induced response. This probably reflected a down regulation of
the beta adrenergic signal transduction mechanism in the presence
5of both con A and PMA.
In conclusion, it appears that the inhibitory effects of the
adrenergic drugs on 3H-thymidine incorporation-in rat spleen
lymphocytes might be mediated by an activation of the specific
beta adrenergic receptor leading to an increase in cAMP
accumulation. On the other hand, an elevated calcium level and an
increase in protein kinase C activity are both stimulatory.
Cyclic AMP produced by beta adrenergic activation may suppress
lymphocyte proliferation by inhibiting either the protein kinase
C, or the regulatory signals acting synergistically with protein
kinase C, or the obligatory steps in DNA synthesis.
CHAPTER ONE
INTRODUCTION
11 Neuromodula ti on of Immuni
The immune system helps the proper functioning of an
organism by fighting against foreign invaders. The immune
responses are, however, stringently controlled so that they are
detrimentous only to foreign invaders but remain harmless to the
host's own components.
Immune responses are regulated, to a large extent, by the
immune system itself, involving a network of helper and
suppressor T cells and their products, antibody feedback systems,
idiotypic-anti-idiotypic network of interacting antibodies and
other regulatory factors (Besedovsky et al., 1981). The immune
responses are also under the control of the nervous and endocrine
systems. For instance, various immunity parameters including
spleen cell number, thymus cell number, splenic mitogen
responsiveness, thymocyte mitogen responsiveness, antigen
responsiveness, natural killer cell activity and macrophage
suppressor cell activity are affected by either lesions in the
anterior hypothalamus, hippocampus or amydala (Roszman et al.,
1985). It is also well known that the psychological state can
affect one's immunity. For instance, the response of men's
lymphocytes to an activating agent declined significantly within
a month or two after the deaths of their wives (Besedovsky et
al., 1981). Students taking examinations were found to have a
reduction in their helper T cell and natural killer cell
activities (Marx, 1985). Moreover, classical conditioning is able
to- a lter one's immune response (Ader et al., 1983) e.g. the
2repeated association of a neutral conditioned stimulus with
antigenic stimulation could increase antibody production when
animals were later re-exposed to the conditioned stimulus alone.
Both the nervous and the endocrine systems are able to
secrete chemical messengers (neurotransmitters or hormones) which
upon interacting with their specific receptors in the target
organs can affect their biological activites. Indeed, many such
mediators including adrenocorticotropic hormone, bombesin,
endorphins, enkephalins, neurotensin, substance P, somatostatin,
vasoactive intestinal peptide (0' Dorisio et al., 1985 Payan and
Goetzl, 1985 Smith et al., 1985), arginine vasopressin, oxytocin
(Johnson and Torres, 1985), insulin (Snow, 1985), prolactin
(Russell et al., 1984), glucocorticoids (Ranelletti et al.,
1987), serotonin (Jackson et al., 1985), norepinephrine and
acetylcholine (see below) can exert their action on the immune
system and/or have their respective receptors on the immune
cells. Indeed, various lymphoid organs including the thymus,
spleen, lymph nodes, gut-associated lymphoid tissue and bone
marrow are innervated by the sympathetic noradrenergic nerve
fibers and possibly peptidergic neurones as well (Felten et al.,
1985). Such innervation is directed into regions of T lympocytes
and the antibody producing plasma cells, but avoiding zones of
developing B lymphocytes (Felten et al., 1985). Since surgical
and chemical sympathectomy can increase the number of antibody
forming cells, it has been suggested that the sympathetic nervous
system may have a suppressive role on the immune system
(Besedovsky et al., 1981 Felten et al., 1985). Furthermore, such
3nerve innervation might even affect development and migration of
cells into and out of the immune organs (Marx, 1985).
1.1.1 Adrenergic Action on Immune Responses
Local surgical denervation of the spleen as well as chemical
sympathectomy by 6-hydroxy-dopamine followed by adrenalectomy
have been shown to increase the number of antibody forming cells
after immunization (Besedovsky et al., 1981). The norepinephrine
content of the rat spleen decreases markedly on days 3 and 4
after the animal is challenged with sheep red blood cells. This
decrease is more dramatic when the magnitude of the animal's
immune response was high (del Rey et al., 1982). The turnover
rate of norepinephrine is also lowered in the immunized rats (del
Rey et al., 1982) reflecting a reduced synthesis and release of
the biogenic amine. The norepinephrine level in the spleen of
specific pathogen-free rats, which are constantly exposed to
external antigens, is about half of that in the spleen of germ-
free rats, which are exposed to a minimal degree of external
antigenic challenge (del Rey et al., 1981). This association of
low norepinephrine level in spleen with high immune response may
be conveniently explained on the ground that norepinephrine is
immunosuppressive. Thus, a decrease in norepinephrine may
relieve the inhibition on the spleen cells and result in a higher
immune response.
41.1.2 Adreneric Receptors in The Immune System
The biological effects of norepinephrine and epinephrine are
generally believed to occur as a result of the interaction of
these catecholamines with specific receptors on the external
surface of specific target cells (Minneman et al., 1981). Alquist
(1948) proposed that there are two distinct types of adrenergic
receptors, namely, the alpha and the beta adrenergic receptors.
Alpha adrenergic activation is typified by smooth muscle
contraction in which epinephrine is the most potent, with
norepinephrine being equipotent or slightly less potent, and the
synthetic amine isoproterenol being very weak. Beta adrenergic
activation is typified by smooth muscle relaxation in which
isoproterenol is the most potent, with epinephrine and
norepinephrine being slightly weaker
Alpha adrenergic receptor activation can increase the rate
of E-rosette formation (T lymphocyte marker) (Xu and Chen, 1985)
but inhibit the plaque forming cells and T-lymphocyte
transformation (Besedovsky et al., 1979). On the other hand,
beta adrenergic receptor activation can inhibit various B
lymphocyte, T lymphocyte and macrophage functions e. g. lymphocyte
mediated cytotoxicity, lymphocyte transformation and E-rosette
formation. An increase in EAC-rosette (B lymphocyte marker)
formation, however, has also been reported (Xu and Chen, 1985).
51.1.3 Cholinergic Action on Immune Responses
Cholinergic activation of lymphocytes is able to elicit an
increase in intracellular cGMP level (Illiano et al. 1973) as
well as an increase in RNA and protein synthesis (Hadden et al.,
1975). Acetylcholine and carbachol, which are cholinergic
agonis ts, can also depolarize the membranes of the T but not that
of B lymphocytes (Shapiro and Strom, 1980). Immune parameters
such as T-lymphocyte cytotoxicity (Strom et al., 1974),
lymphocyte motility (Schreiner and Unanue, 1975), mitogen
responsiveness (Illiano et al., 1973 Giliette et al., 1974
Richman and Arnason, 1979) and alloimmune-induced DNA synthesis
(Strom et al., 1975) are all enhanced by cholinergic activation.
1.1.4 Cholinergic Receptors in The Immune System
Cholinergic receptors can be divided into the muscarinic and
the nicotinic subtypes. The former can be activated by muscarine
but inhibited by atropine. The latter can be activated by
nicotine but inhibited by d-tubocurarine (Mayer, 1980). Since the
various cholinergic responses described in section 1.1.3 are
inhibited by atropine, they may be described as the muscarinic
responses. In fact, by direct radioreceptor assay, the existence
of muscarinic cholinergic receptors has been demonstrated in the
lymphocytes of the rat (Shenkman et al., 1986) and human (Zalcman
et al., 1981). Although Strom' s group (1978) detected a
muscarinic binding in the T but not the B lymphocytes, Atweh and
6coworkers (1984) were able to detect the binding in both
lymphocyte populations. Two types of muscarinic cholinergic
receptors differing in binding affinities have also been reported
(Richman and Arnason, 1979). Richman and Arnason (1979) also
reported the existence of nicotinic receptors on lymphocytes
which are able to inhibit proliferation upon activation.
1.2 Lymphocyte Proliferation
Of the various immune responses, lymphocyte proliferation is
one of the central and basic requirement for the generation of
immunity. Before one goes into the details of lymphocyte
proliferation, it is useful to consider some aspects of the
development of lymphocytes first.
1.2.1 Development of B Lymphocytes
B lymphocytes are responsible for the humoral antibody
synthesis. They are developed in the Bursa of Fabricius in birds
and hence the term, B lymphocytes. The equivalent of Bursa of
Fabricius in mammals have not yet been identified but the most
probable sources of B cells are the fetal liver and spleen as
well as the bone marrow in adults (Roitt et al., 1985 Whitlock
et al., 1985).
Murine B cell development can be divided into three phases
7(Whitlock et al., 1985). Firstly, pluripotent haema topoietic
stem cells are committed to the B cell pathway. They undergo
immunoglobulin genes rearrangement and subsequent expression of
Ig1 and IgD of the same specificity on their surface. Secondly,
they have to migrate to and accumulate in peripheral lymphoid
organs e. g. the spleen as resting B cells which can be activated
by antigen and helper factors produced by T lymphocytes and
accessory cells. Thirdly, the activated B cells can proliferate
and differentiate into antibody producing plasma cells.
1. 2.2 Development of T Lymphocytes
T lymphocytes are responsible for the cell mediated immune
responses and they work in co-operation with B cells in the
humoral antibody production. Precursors of T cells are produced
in the bone marrow and they mature in the thymus under the
influence of thymic hormones. Pre-T cells leave the bone marrow
and migrate (Jotereau et al., 1980) to the thymus as a result of
the concentration gradient of the thymic chemotactic factors.
They then mature in the thymus as Lyt. 1+ and Lyt. 123+ cells
which are known as the (T1) post-thymic precursor cells. These
post-thymic precursor cells leave the thymus without passing
through the thymic medulla and enter the periphery giving rise to
T2 cell subsets: Lyt. 1+ helper T cells and Lyt. (1)23+
suppressor/cytotoxic T cells (Bach and Papiernik., 1981).
81.2.3 Lymphocyte Growth Factors
Lymphocyte proliferation is facilitated by soluble factors
produced by immune cells. They include:
a) Interleukin 1 (I l-1), which is also known as the lymphocyte
activating factor (Male, 1986). It is produced by mononuclear
phagocytes when activated by antigens, lectins, lymphokines,
phorbol esters, micro-organisms and various inflammatory agents
(Gearing et al., 1985). It is able to induce interleukin 2 (I1-2)
receptors on T cells (Male, 1986) and stimulate the production of
Il-2 by T-cells (Smith, 1980).
b) Interleukin 2, which is originally known as the T cell
growth factor. It is secreted mainly by the helper T cells when
activated by lectins, antigens, calcium ionophores plus phorbol
myristate acetate (Delia et al., 1984). Besides promoting T cell
proliferation, Il-2 can- also stimulate non T cell immune
responses such as natural killer cell activity, lymphocyte
activated killer cell activity and antibody secretion (Robb,
1984).
c) Interleukin 3 (I1-3) which is produced by lectin activated
helper T cells and a number of leucocyte derived cell lines.
Probably because of its ability to stimulate the proliferation of
immature pluripotent cells, I1-3 has a wide range of biological
activities many of which belong to the colony stimulating type
9(Gearing et al., 1985).
d) B cell growth factors:
Besides being able to produce 11-2, activated helper T cells
can also secrete two other lymphokines, namely the B cell growth
factors (BOGF) I and II. They can stimulate activated B cells to
proliferate. A third lymphokine, the B cell mitogenic factor
(BMF) can cause the resting B cells to proliferate and to produce
antibody. Fig. I is a simplified representation of the actions of
various interleukins and B cell growth factors (Gearing et al.,
1985).
1.2.4 Mitogens
Mitogens are molecules which can induce cell division and
differentiation (Male, 1986). Mitogenic stimulation of
lymphocytes in vitro is thought to mimic the series of events
elicited by antigens on lymphocytes in vivo. Commonly used
mitogens include concanavalin A (con A) and phytohaemagglutinin
(PHA) which are specific for T lymphocytes and 1 ipopolysaccha ride
(LPS) and dextran sulphate which are specific for B lymphocytes
(Roitt at al., 1985). In my study, I employed con A as a T
lymphocyte mitogen and LPS as a B lymphocyte mitogen.
1.2.4.1 Concanavalin A (Con A)
Stem Cell
Proliferattor










Fig. I Simplified diagram showing the involvement of the
interleukins in leucocyte proliferation.
represents antigen or lectin stimulation of monocytes
(Md) or lymphocytes: cytotoxicsuppressor);
helper (TH).
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Lectins are bivalent or polyvalent carbohydrate binding
proteins (Goldstein et al., 1980). Among the various plant
lectins, con A is the best characterized. It comprises up to 15%
of the proteins in the cotyledons of the jack bean (Canavalia
ensiformis) seeds (Carrington et al., 1985). It carries no
carbohydrate moiety and exists as a tetramer at pH 7.0-7.5 with a
subunit molecular weight of about 25,500. Each subunit contains
one saccharide binding site, one calcium ion and one manganese
ion. The metal ions are probably responsible for maintaining the
correct conformation of the molecule (Ling and Kay, 1975b).
Con A exerts its action by binding to the lymphocyte surface
for a restricted time (Novogrodsky and Katchaiski, 1971 Soren,
1973) without entering the cells (Greaves et al., 1972b). It
binds specifically to the u -D-glucopyranosides, a -D-
mannopyranosides, and polysaccharides or glycoproteins containing
such residues (Summer et al., 1936). The saccharide binding
activity depends on the calcium ion and manganese ion it contains
(Yarvi et al., 1968). Since con A is multivalent, it can cross-
link receptors between cells leading to the cell agglutinating
phenomenon (Gunther et al., 1973).
The cellular reactions mediated by con A can be divided into
the immediate versus the delayed type. The immediate type
includes: con A receptor capping and patching increase in
glucose, nucleoside and potassium transport increase in
phospholipid synthesis increase in cytosolic calcium, cAMP and
12
WMP levels Wadden et al., 1976). The delayed type reaction
refers to the mitogenic action of con A on lymphocytes. Al t,-hough
both T and B lymphocytes bind a maximum of 107 con A molecule:
per cell, only T but not B lymphocytes exhibit a mitogenic
response. Nevertheless, B lymphocytes may still be subjected to a
certain degree of indirect stimulation from con A as a result of
the diffused products of T lymphocytes (Ling and Kay, 1975c).
Resting B lymphocytes can also be driven into a transitional
activation state between the deep quiescence and G. phase by con
A (Hawrylowicz and Klaus, 1984).
1.2.4.2 Lipopolysaccharide (LPS)
LPS are endotoxins usually found in Gram negative bacteria
and consist of a lipid component called lipid A and a
polysaccharide component. Those produced by E. coli 0113 and 0111
: B4 are mitogenic for mouse and rat spleen cells (Ling and Kay,
1975b). Although they are able to bind to both T and B
lymphocytes, they are only mitogenic for the B lymphocytes
(Greaves and Bauminger, 1972). Among the B lymphocyte population,
only about 20% is responsive (Janossy et al., 1973). LPS has
also been shown to activate macrophage to secrete interleukin 1,
interferons, and prostaglandins (Kurland et al., 1978) and to
cause the release of factors from lymphoid cells which are
mitogenic for thymocytes (Gery et al., 1972).
Upon incubation, LPS speeds up the phenotypic maturation of
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pre-B lymphocytes and immature B lymphocytes to the mature stage.
It also induces mature B lymphocytes to proliferate and
differentiate into the antibody producing plasma cells (Andersson
et al., 1972a,1972b Hammerling et al., 1976).
Like con A, LPS exerts its mitogenic effect without entering
the cell (Greaves and Janossy, 1972). For the Coli and Salmonella
LPS, the lipid portion of LPS is believed to be mitogenic
(Andersson et al., 1973 Peavy et al. 1973 Rosenstreich et al.,
1973). Lipid A probably interacts with the lipid bilayer of cell
membrane to produce critical changes in the conformation of
membrane proteins or other components to trigger off mitogenesis
(Andersson et al., 1973).
1.2.5 The Cell Circle
The eucaryotic cell cycle can be subdivided into four phases
(Howard and Pelc, 1953 $arserga, 1981), i.e. the pre-DNA
synthesis (G1), the DNA synthesis (S), the post DNA synthesis (G2
) and the mitosis (M) phase. Following mitosis, the cell may
either re-enter the cycle or enter the resting Go phase in
which the cell is not committed to cell division (Berridge,
1985). It is generally agreed that the S phase occupies half the
time of a cycle while the remaining is split equally between Cl
and G2+ mitosis (Marshall and Roberts, 1965 Sasaki and Norman,
1966). Nevertheless, variations exist in length of G1, S, and G2
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phases (Steffen and Stolzman, 1969). For example, it was found
that most lymphocytes entered their first period of DNA synthesis
between 48 and 72 hours after phytohaemagglutinin (PHA) addition
but some entered at 24 hours and others at more than 100 hours
(Ling and Kay, 1975d).
The small lymphocyte is nearly dormant and proliferatively
inactive. It has a highly condensed chromatin, a reduced nuclear
matrix, poorly developed Golgi apparatus, few mitochondria and
polysomes. The cell cycle genes are also turned off. After the
addition of a mitogen like concanavalin A (con A), the chromatin
de-condenses and early cell cycle genes are turned on. The
nuclear matrix expands. The number of mitochondria also
increases. Ribosomes are made and transported into the cytoplasm.
With this new synthetic machinery in place, proteins and enzymes
are made and transported into the nucleus to trigger off DNA
replication (Whitfield et al., 1985).
1.2.6 3 H Thymidine Incorporation
Lymphocyte proliferation is accompanied by an enlargement of
cells e.g. the blast cells. People used to count the number of
enlarged cells in cultures as an indication of proliferation.
Since proliferating cells can pick up 3H-thymidine from the
medium into their DNA, radiometric techniques can be used to
measure the loss of radioactivity from the medium which reflects
the degree of cell proliferation. A more commonly employed
method, however, is to measure directly the amount of JH-
thymidine incorporated into the cell (Carr et al., 1972). This
assay method has been claimed to be the most reproducible,
quantitative and sensitive assay of lymphocyte proliferation
(Oppenheim, 1969) and was used in my experiments to study
lymphocyte proliferation.
1.3 The cAMP Signalling Pathway
The hormonally regulated adenylate cyclase system is
composed of at least five types of components: the catalytic
moiety of adenylate cyclase (C), the stimulatory (G) and the
nhibitory (GJ guanine nucleotide regulatory proteins, and the
stimulatory (R) and the inhibitory (Ft) cell surface receptors.
.Both G and G- are multimeric proteins consisting of a,P
and y subunits (Gilman, 1984; Helmreich and Pfeuffer, 1985).
The beta adrenergic receptor is a stimulatory (Rg) receptor
which interacts with Gs resulting in an exchange of GTP for GDP
on the a subunit of Gs. This is followed by the dissociation of
G into GTP. as and Ps Vs. GTP.as in turn activates C to give
cAMP from ATP. A rise in intracellular cAMP level is thus to be
expected with the binding of adrenergic agonists to beta
receptors on the cell surface (Gilman, 1984; Helmreich and














Fig. II The beta adrenergic receptor linked
adenylate cyclase system
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1.3.1 Cyclic AMP and Lymphocyte Proliferation
The action of cAMP on lymphocyte proliferation is two fold:
both inhibitory and stimulatory effects have been observed.
Cyclic AMP and dibutyryl cAMP were found to inhibit DNA
synthesis in rat thymocytes (MacManus and Whitfield, 1970), human
lymphocytes, human leukemic lymphocytes (Abell et al., 1970
Johnson and Abell, 1970) and mouse spleen lymphocytes
(Diamantstein and Ulmer, 1975 Watson, 1976). On the contrary,
cAMP has also been reported to stimulate DNA synthesis in
lymphocytes (MacManus and Whitfield, 1970). Intraperitoneal
injection of cAMP or its dibutyryl derivative in rats also
increases the number of bone marrow and thymus cells that enters
mitosis (Rixon et al., 1970). The transforming protein produced
by the ras gene, which may contribute to cancer development in
malignant cells and regulation of growth and differentiation in
normal cells, is an activator of the adenylate cyclase in yeast
(Marx, 1984). All of these evidence argue for a positive role of
cAMP in cell proliferation. Still other investigators could find
no effect of cAMP on lymphocyte proliferation (Averner et al.,
1972 Watson, 1975).
Such discrepancies may sometimes, although not always, be
resolved by the fact that low concentrations of cAMP or its
dibutyryl derivative (10-8 -10 6 M) stimulate DNA synthesis
whereas high concentrations (between 1 (:4 -10 3 M) cause
18
inhibition (MacManus and Whitfield, 1970).
1.3.2 clic AMP and Con A
Low concentration of con A which stimulates DNA synthesis
has been found to inhibit adenylate cyclase activity in broken
cell preparation of lymphocytes (Krug et al., 1972). However, at
high concentration, con A inhibits DNA synthesis but stimulates
adenylate cyclase activity. Similar observations have been made
by other workers in intact human lymphocytes (Kaever and Resch,
1985 Hadden et al., 1976). Supraoptimal concentration of con A
leads to a dramatic increase of cAMP level in the lymphocytes
which may be responsible for the diminished DNA synthesis.
Corresponding concentration of a con A derivative, succinyl con
A, which did not increase cAMP also has no effect on the
mitogenic response of lymphocytes. Cyclic AMP in these
experiments was again assigned a negative role in lymphocyte
proliferation. However, it should be noted that at optimal
mitogenic con A concentration, cAMP did increase slightly (Kaever
and Resch, 1985 Hadden et al., 1976). The large increase in cAMP
induced by supraoptimal con A concentration may be due to the
agglutinating properties of con A (Hadden et al., 1976) or the
con A induced receptor capping phenomenon (Bourguignon and Hsing,
1983).
1,3:3 clic AMP and LPS
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Mitogenic concentrations of LPS cause little or no change in
cAMP content in murine spleen cultures (Watson, 1975). More
recently, the LPS mitogenic activity has been implicated to be
mediated through the action of Gi, an inhibitory guanine
nucleotide regulatory protein of the adenyate cyclase system
(Jakway and DeFranco, 1986). For instance, pertussis toxin
inhibits the LPS induced mitogenic responses of the WEHI-231 Bl
lymphoma cell line and the P388D1 macrophage cell line. Since
pertussis toxin can inactivate G. through adenosine diphosphate
ribosylation (Bockoch et al., 1983), it is possible that the LPS
signal is transduced through a G i receptor-effector coupling
mechanism. Moreover, LPS has been demonstrated to inhibit
adenylate cyclase activity in P388D1 cells. LPS activation may
thus decrease the intracellular cAMP level and relieve cAMP
mediated inhibition of cellular responses (Jakway and DeFranco,
1986).
1.3.4 clic AMP and The Cell Cycle
In the lymphocyte cell cycle, cAMP levels are highest in G
and G2 phases. The levels at S phase and mitosis are only 20%
that of the G 2 phase (Millis et al., 1972).
It has been observed that the transition from G. to Gl is
associated with a fall in cAMP (Otten et al., 1972 Frank, 1972).
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Since an increase in cAMP level occurs within 15 min after the
addition of mitogenic concentrations of PHA, it may be an early
signal in the G 1 phase of lymphocytes (Krishnaraj and Talwar,
1973). However, other investigators have found that cAMP level in
mouse spleen lymphocytes only rised '10 hours after exposure to
mi togen, peaked around 20 hours, and then dropped before DNA
synthesis peaked at 50 hours (Foker et al., 1979 Whitfield et
al. 9 1980)
Cyclic AMP and protein kinase A have been postulated by
Boynton and Whitfield (1983) to play a critical role in the pre-
replicative events at the end of G1 phase and in the pre-mitotic
events. They also suggest that cAMP when generated at the right
time at an appropriate level may promote cell cycle transit.
However, it can block the cell cycle if generated at an abnormal
amount at the wrong time.
1.4 The Phosphatidylinositol 4,5-Bisphosphate Pathwa
In addition to changes in cAMP level, an elevated calcium
ion level (Berridge, 1975 Metcalfe et al., 1980 Durham and
Walton, 1982) and the activation of a neutral Na+ /H+ exchange
carrier (Moolenaar et al., 1981, 1982, 1983) may also contribute
to the onset of cell proliferation. Since the
phosphatidylinositol bisphosphate (PIP2) signalling mechanism is
involved in these biochemical changes (see below), it is not
surprising that it has been a focus of research in lymphocyte
21
proliferation in recent years (Isakov et al., 1986).
The interaction of an external growth signal with the
appropriate plasma membrane receptor can activate a PIP2 specific
phosphodiesterase, the phospholipase C, through a guanine
nucleotide binding protein. Upon activation, it hydrolyses the
plasma membrane PIP to diacylglycerol (DG) and inositol 1,4,5-
2
trisphosphate (IP 3). These second messengers then act
synergistically to elicit cellular responses in lymphocytes (Fig.
III) (Mastro and Smith, 1983 Rozengurt, 1986). Con A has been
found to enhance the PIP2 turnover rate in lymphocytes (Sugiura
and Waku, 1984) while no such change has been observed for LPS
(Bijsterbosch et al., 1985).
1.4.1 Calcium and Lymphocyte Proliferation
Activation of the PIP2 pathway can cause an initial
transient release of calcium. from an intracellular store and a
more sustained entry from the extracellular space.
IP3, one of the immediate product of PIP2 hydrolysis, is
able to release calcium from a non-mitochondrial intracellular
store, probably the endoplasmic reticulum (Strab et al., 1983).
IP 3 binds to a specific receptor (Spat et al., 1986) and opens
a calcium channel (Muallem et al., 1985) on the endoplasmic































IP can be phosphorylated to inositol 1,3,4,5-tetrakis-
3
phosphate (IP4) (Batty et al., 1985 Irvine et al., 1986) which
can act synergistically with a fall in the intracellular calcium
pool to provoke calcium entry from the extracellular space
(Taylor, 1987).
To switch off the signal, IP and IP4 are dephosphorylated
3
to give inositol 1,4-bisphosphate (Taylor, 1987). Eventual
dephosphorylation of the inositol phosphate yields the myo-
inositol which can be used for the resynthesis of PIP (Berridge,
2
1984, 1985) (see Fig. IV).
When lymphocyte proliferation is stimulated by antigens,
PHA, con A or calcium ionophore, there is a transient (0-6 hrs)
small (0.1-1.0 uM) rise of intracellular calcium level.
Extracellular calcium is required again between 19 and 47 hours
to start chromosome replication (Mastro and Smith, 1982). The
increase in intracellular calcium levels may directly or
indirectly stimulate the transcription and translation of early
genes in the cell cycle and increase the activity of their gene
products. It also triggers the entry of replication enzymes and
initiator protein(s) into the nucleus, mobilizes tubulin from the
cytoskeletonj to form the spindle, operates the spindle mechanism
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Fig. IV The turnover of phosphatidylinositol 4,5-bisphosphate
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1.4.2 Protein Kinase C and Lymphocyte Proliferation
Protein kinase C was discovered in 1977 (Takai et al., 1977)
and is widely distributed in many tissues. It is a phospholipid
and calcium dependent serine/threonine protein kinase (Nishizuka,
1984a,1984b Nishizuka et al., 1984). It comprises two functional
domains: a regulatory hydrophobic domain which binds to the cell
membrane upon activation and a hydrophilic domain which carries
the catalytic site.
Activation of protein kinase C can be accomplished by DG,
which is one of the PIP hydrolysis products. Derivatives of DG
such as 1-oleoyl-2-acetyl-3-phosphoryl-glycerol (Nishizuka et
al., 1984) and phorbol esters extracted from the seeds of Croton
tiglium (Kolata, 1983) are also activators of protein kinase C.
The affinity of protein kinase C for calcium and
phosphatidylserine is dramatically increased by a small amount of
DG. Upon activation, the enzyme is translocated from the cytosol
to the plasma membrane. When DG is catabolized, protein kinase C
is inactivated again. Alternatively, protein kinase C can be
activated irreversibly by proteolysis although the physiological
significance of such activation is not well understood (Murray et
al., 1987).
The action of DG can be terminated by hydrolysis through
diacylglycerol lipase to monoacylglycerol and fatty acid (usually
arachidonic acid). DG can also be converted to phospha tida to by
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diacylglycerol kinase for the resynthesis of PIP2 (Berridge,
1984).
The Na+ /H+ exchanger can be activated by phosphorylation
through protein kinase C and thus exchanges extracellular Na+ for
intracellular protons resulting in an increase in intracellular
Na' level and pH (Isakov et al., 1986). Other target proteins
phosphorylated by protein kinase C include the IL-2 receptor
(Shackelford and Trowbridge, 1984), guanylate cyclase (Zwiller et
al., 1985), glucose transporter (litters et al., 1985), tyrosine
specific kinase (Hirata et al., 1984) and protein kinase C itself
(Bell, 1986).
Like calcium mobilization, protein kinase C activation may
be involved in the transcription of early genes in the cell
cycle, translation of the gene transcripts produced and
activation of the gene products as well as in mitosis and
cytoplasmic division (Whitfield et al., 1985).
1.4.3 DG, Phospholipids, cAMP and Cell Proliferation
As mentioned above, arachidonic acid can be produced from DCT
by the action of diacyglycerol lipase. It can also be produced
from phosphatidate by a phosphatidate specific phospholipase A2
and from phosphatidy lcholine, phospha tidy 1 ethanolamine and
phospha tidylinositol by a less specific phospholipase.
Arachidonic acid can then be converted to the E-type
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prostaglandins which may leave the cell and stimulate cAMP
production -through specific prostaglandin receptors. The cAMP
thus accumulated may play a role in the initiation of DNA
synthesis in Swiss 3T3 cells (Rozengurt, 1986). Whether such a







250-350 g male Sprague-Dawley rats supplied by the
University Animal House, The Chinese University of Hong Kong were
used throughout the experiments.
A23187
A23187 was purchased from Sigma. It was first dissolved in
dime thylsulphoxide (DMSO) (Merck) to give a 10 mM stock and
diluted with PBS to the appropriate concentrations.
Adrenergic drugs
The adrenergic drugs used include (-)-isoproterenol-
bitartrate (Sigma), (-)-norepinephrine-HC1 (Sigma), and(-)-
epinephrine (Sigma). Drug solutions were freshly prepared before
each experiment and made sterile by passing through a millipore
filter (0.45 um)'.
Atropine
Atropine-sulphate purchased from Sigma was stored dessicated
in the dark at room temperature. It was freshly prepared before
each experiment.
Charcoal solution
Neutral activated charcoal was ors Layri('u 11-U111 IJ161ibca al Iu
prepared at a concentration of 75 mg/ml in the cAMP assay buffer
containing 2% BSA.
Complete medium
Under sterilized conditions, complete medium was prepared by
adding 88 ml RPMI 1640 culture medium to 10 ml FCS, 1 ml PS and 1
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ml fungizone to give a final concentration of 10% FCS and 1% of
PS and fungizone.
3U-Cyclic adenosine 3',5'-monophosphate (3H-cAMP)
3 H-cAMP from Amersham with a specific activity of 23.6
Ci/mmole was freshly prepared each time at a concentration of 18
nr-1 in the cAMP assay buffer.
cAMP standard
The stock concentration of cAMP standard (Amersham) was 16
pmoles/50u1. It was diluted with the cAMP assay buffer serially
to give 8, 4, 2, 1 pmoles/50ul standard cAMP solutions.
cATMlP assay buffer
The cAMP assay buffer contained 50 mM Tris-HC1 and 4 mM Na
EDTA at a pH of 7.4 at room temperature.
cAMP binding proteins
The cAMP binding protein was prepared according to the
method of Brown et al. (1972). Bovine adrenal glands were freshly
obtained from a local slaughter house. Fatty tissues on the
surface were first trimmed off. The adrenal medulla was separated
from the cortex and homogenized in 1.5 volume (v/w) of a solution
containing 0.25 M sucrose, 25 mM KC1, 5 mM MgCl 2 and 50 mM Tris-
HCl at pH 7.4 at room temperature. The homogenate was centrifuged
at 10,000 x g for 5 min at 4°C. The supernatant was collected and
centrifuged at 10,000 x g for another 15 min. The supernatant
thus obtained was divided into 500 ul aliquots and stored at
-20 °C. Preparations of the cAMP binding protein was thawed and
diluted 25 fold before used in the cAMP assay.
3H-Dihvdroalprenolol (3H-DHA)
11 DMA toving a specific activity of 33 Cimmolc was
obtained from Amersham and stored at -20 °0. Stock working
solution was prepared at a concentration of 10 nM.
Ethylenediamine tetraacetic acid (EOTA)
Disodium salt of EOT A from Mallinckrodt was used in the cAMP
assay buffer.
Dibutyryl cAMP
N 2' -G-Dibutyryl adenosine 3',5'-cyclic monophosphate was
obtained from Sigma and stored at -20°C at 10 mM aliquots.
Fetal calf serum (FCS)
Fetal calf serum (Gibco) vas stored in 10 ml aliquots at
-20°C. The final concentration used was 10% in RPMI medium.
Fungizone
Stock solutions of fungizone (300 ugml) vas purchased from
Gibco and stored in 5 ml aliquots at -20°C.
3-Isobutyl 1-methylxanthine (IBMX)
IBMX (Research Biochemicals Inc.) was first dissolved in
absolute ethanol at 10 mM and then diluted to the appropriate
concentrations with PBS.
Mitogens
Mitogens used included concanavalin A (con A) and
Et_ coli. 0128:B12 lipopolysaccharide (LPS). Both were obtained
from Sigma. They were dissolved in PBS at a concentration of 1
mgml and stored at -20 C in 0.3 ml aliquots.
H-Para-aminoclonidine (3H-PAC)
3H-PAC having a specific activity of 40 Cimmole vas
obtained from Amersham and diluted to a stock concentration of 10
nM for use in radioreceptor assays. It was stored at -20 0.
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Penicillin-streptomycin (PS)
Stock penicillin-streptomycin solution containing 10,000
units/ml of pencillin G and 10,000 ug/ml of streptomycin sulfate
was purchased from Gibco and stored in 5 ml aliquots at -20 °C.
The final concentration used was 1% of this stock solution.
Phorbol 12-myristate 13-acetate (PMA)
PMA was purchased from Sigma. It was first dissolved in D[4S0
(Merck) at 5mg/ml and diluted to the appropriate concentrations
with PBS.
Phosphate buffered saline (PBS)
PBS was prepared by dissolving 4 g NaCl, 0.1 g KC1, 0.57 g
Na2HP04.12H20 and 0.1 g KH2PO4 in 500 ml distilled water. The pH
of the solution was then adjusted to 7.2 and made sterile by
autoclaving at 121°C for 30 min.
1-Quinuclidinyl-(phenyl-4-3H)-benzilate( 3 H-QNB,
3 H-QNB (Amersham) with a specific activity of 38 Ci/mmole
was stored at -20 °C. The stock concentration used in the
radioreceptor assays was 20 *rir4.
RPM 1640 culture medium
RPr4I 1640 medium with 25 mM HEPES was purchased from Sigma
in powdered form. Each bottle of RPMI powder was made up to one
litre in distilled water. Two grams of sodium bicarbonate were
added and the pH was then adjusted to 7.2. The solution was made
sterile by passing through a millipore filter (0.45 um) under
section.
Scintillant
Scintillation fluid for radioreceptor assays containea u. ii g
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192-bis(295-phenyloxazolyl)benzene (POPOP) and 4 g 2,5-
diphenyloxazole (PPO) in one litre mixture of 666 ml toluene and
333 ml Triton X-100 awhile that for 31-thymidine incorporation
comprised of 0.125 g POPOP and 15 g PPO in 2.5 litres of toluene.
Theophv l l ine
Theophy l l ine was obtained from Sigma. It was used as a cA!
phosphodiesterase inhibitor.
3H-Thymidine
3H-Thymidine from Amersham with a specific activity of 2
Ci/mmole was diluted two fold with PBS to 0.5 Ci/ul for use in
pulse labelling assay of lymphocyte proliferation. It was stored
at4°C.
Tris buffered isotonic ammonium chloride solution (Lysing
Solution)
Ninety ml of 0.16 M ammonium chloride (FU)H) solution was
mixed with 10 ml of 0.17 M Tris-HC1 (Sigma). The resulting
solution was then adjusted to pHH 7.2 with 1 M NaOH and sterilized
by passing through a millipore filter (0.45 um).
Tr\Uan blue solution
0.2% trypan blue (Sigma) solution was prepared in P13S and
used to check the viability of lymphocytes.
3 H-VIB4101
3H-IVB4101 (Amersham) having a specific activity of 27
Ci/mmole was stored at -20°C. Stock working solution was prepared







Fig. V Chemical structure of 3H-WB4101
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2.2 Methods
2.2.1 Preparation of Spleen Lymphocytes
Sprague-Dawley rats were killed by cervical dislocation. The
spleen was removed and put into cold RPMI 1640 medium. It was
then minced in the medium over a sterile 60 mesh stainless steel
screen. Spleen lymphocytes that passed through the sieve were
collected and centrifuged at 300 x g. The pellet was resuspended
in 10 ml RPMI 1640 medium and centrifuged again at 300 x g.
Finally, complete medium was used to resuspend the pellet and the
cell concentration was adjusted to the required level (see below)
after counting the number of cells with a haemacytometer.
2.2,2 Cell Counting
Twenty microliters of the cell suspension were diluted with
980 ul PBS. An aliquot of this diluted cell suspension (100 ul)
was added to an equal volume of trypan blue solution and then
applied to the haemacytometer. Since dead cells were stained blue
in the trypan blue solution, they could be differentiated from
the viable ones (Philip, 1973). The number of viable cells (y)
was counted. The viable cell concentration of the original cell
suspension could then be calculated by the following equation:
2.2.3 Lysis of Red Blood Cells (RBC)
In the case of radioreceptor binding and viability test, red
blood cells (RBC) had to be lysed and removed first in order to
avoid interference from them.
Every 0.1 ml cell pellet collected after the first
centrifugation was resuspended in 1 ml of lysing solution at room
temperature for 5 min in order to lyse the RBC. The spleen
lymphocytes 'were then washed twice by centrifugation at 300 x g
for 5 min. The cell pellet was finally resuspended in the
complete medium unless otherwise specified.
2.2.A Radioreceptor Assav
Four radioligands, 3H-VB4101, 3H-PAC, 3H-DHA and 3 H-QNB
vere used to test the existence of alpha1 adrenergic, alpha2
adrenergic, beta adrenergic, and muscarinic cholinergic receptors
on the rat spleen lymphocytes respectively.
The rat spleen lymphocytes without RBC vere prepared as
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described earlier except that PBS was used as the medium. The
binding studies were similar for all three radioligands.
Essentially, 50 ul of the radioligand, 50 ul of the displacer or
buffer and 400 ul of the cell suspension were mixed together and
incubated at an indicated temperature for an indicated period of
time to ensure an equilibrium of binding (see Table I). The
mixture was vortexed from time to time to prevent the cells from
sedimenting under gravity. At the end of the incubation, the
mixture was filtered through Whatman GF/B glass fibre filter
under suction. The filters were washed 5 times using 5 x 3 ml
cold PBS.
Nonspecific binding is defined as binding in the presence of
an excess of displacer. By subtracting non-specific binding from
total binding, one can obtain the specific binding for each
radioligand.
2.2.5 Stimulation of cAMP Production
Rat spleen lymphocytes were prepared as previously described
except that PBS, instead of RPMI 1640 medium, was used as the
buffer medium throughout the experiment.
The spleen lymphocyte preparation was adjusted to a cell
concentration of 3 x 107/ml and preincubated at 37°C for 10 min.
To initiate cAMP accumulation, an aliquot (50 ul) of cell
Table I Conditions for radioreceptor assay
Radioligand Incubation Displaces



















Auspension was added to the 450 ul PBS containing various,
concentrations of isoproterenol and 12.5 mM theophylline. At the
end of an indicated period of incubation, the reaction
stopped by boiling for 4 min. The precipitate was then
centrifuged at 10,000 x g for 15 min at room temperature.
Duplicate aliquots of the supernatant (50 ul) were used for cAT''
determination.
2.2.6 Cyclic AMP Determination
The cANIP determination was based on the cAIP assay kit from
Amersham. It depends on the competition for specific binding to
the cAMP binding protein by radiolabelled and unlabelled cAMP.
When there is more cAP'IP in the unknown sample, less 3H-cAMP will
be bound to the binding proteins and vice versa. With the
introduction of activated charcoal, unbound 3 H-cAMP is adsorbed
and can be removed by centrifugation. The amount of 3H-cAMP bound
to the binding proteins in the supernatant can be determined.
This allows the determination of the amount of cAMP in the
unknown sample by comparison with a standard curve.
Various agents were added into 1.5 ml microfuge tubes as
shown in Table II. Each tube contained 200 ul reagents and was






















Table II cAMP determination assay
At the end of the incubation, an aliquot (100 ul) of an ice-
cold charcoal solution, which had been kept stirred for at least
15 min before use, was added into each tube and mixed. Between 1
and 2 min after the addition of charcoal, the tubes were
centrifuged at 10,000 x g for 2 min at 4°C. An aliquot of the
supernatant (200 ul) was counted by liquid scintillation
spectrometry.
The blank cpm, which was always a few hundred counts per
min, was first subtracted 'from each datum. The specific binding
in the absence of unlabelled cAMP standard (zero standard) was
designated as Co, while that in the presence of unlabel led cAMP
was designated as Cx. The ratio of CoCx could then oe calculated
and a standard cAiP calibration curve can be obtained (Fig. V),
2.2.7 Lymphocyte Culture
Lymphocytes were prepared as described in section 2.2.1.
1—I I I I
Fig. V A typical calibration curve for cAMP determination.
Values presented are the means of duplicated determinations from
one typical experiment. The straight line was determined by
linear regression analysis. Each experiment was accompanied by an
individual calibration curve. Co and Cx are the binding of 3||-
cAMP in the absence and presence of unlabelled cAMP respectivelv.
CONCENTRATION OF cAMP (pmole/tube)
Usually 90 ul of the drugs to be tested, 50 ul of the complete
medium or mitogens in the complete medium and 100 ul of the
lymphocyte suspension were added in sequence to the wells of 96-
well flat bottomed microtiter plates. Mitogens used included
concanavalin A (con A) and lipopolysaccharide (LPS) at an optimal
final concentration of 1 and 10 ugml respectively. Incubation of
the lymphocyte culture was carried out at 37°0 in a humidified
atmosphere containing 5% carbon dioxide (C02) After 48 hours
(except in time dependency experiments), 0,5 uCi of 3H-thymidine
was added into each well. Six hours later, cells were harvested
onto glass fiber filters using a Titertek multiharvester (Flow
Lab. Ltd., U.K.). The radioactivity of H-thymidine incorporated
was then determined by liquid scintillation spectrometry.
2.2.8 Viability Test
The viability tests on lymphocytes were performed at the end
of the 48 hour incubation period. 100 ul of the supernatant was
removed first followed by an addition of 100 ul 0.2% trypan blue
solution to each of the wells. The lymphocytes were then added to
a haemacytometer for assay of viability.
2.2.8 Statistics
All results were expressed as the arithmetic mean_+ standard
deviation. The significance of difference between control and




3.1 Clnracteriza Lion of The Lymphocyte Culture. stetem
3.1.1 Effects of Con A and LPS on 3 H-Thymidine Incorporation
At low concentrations, con A dose-dependently stimulated 3H-
thyrnidine incorporation into the rat spleen lymphocytes (Fig. 1).
However, at concentrations higher than 1 ug/ml the stimulated
response diminished in a dose-dependent manner. Unlike the
biphasic response to con A, 3H-thymidine incorporation was
increased monophasically by increasing concentration of LPS
reaching a plateau at about 10 ug/ml (Fig. 2). Thus, the op ,ima l
doses of con A and LPS at 1 and 10 ug/ml respectively were used
in all subsequent experiments.
3.1 .2 Cell Concentration Dependence of3 H-Thymidine Incorporation
In the absence of con A or LPS, 3 E1-thymidine incorporation
increased almost linearly as the number of cells per well (Fig.
3). In the presence of con A, 3H-thymidine incorporation peaked
at 5 x 105 cells per well but dropped off rapidly at higher cell
concentrations (Fig. 4). In the presence of LPS, 3 H-thymidine
incorporation reached a plateau leveled at 10 6 cells per well
(Fig. 5). Unless otherwise specified, 10 6 cells per well was
chosen for study in all subsequent experiments in the absence of
mitogens whereas 3 x '10 5 cells per well was chosen for





























0 1 2 3 4 5 6
CONCENTRATION OF CON A( ugml)
Fig. 1 Dose response curve of con A-induced 3h~thymidine
incorporation
3 x 103 rat spleen lymphocytes were cultured with different
concentrations of con A in a flat-bottomed 96 well microtiter
plate for 48 hrs at 37°C. Then 0.5 uCi 3H-thymidine was
introduced into each well and incubated for 6 hrs. Finally the
cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. Data given are the
means± S.D. of triplicate determinations. Similar results were
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CONCENTRATION OF LPS( ugml
Fig. 2 Dose response curve of LPS-induced 3H-thymidine
incorporation
3 x 10 rat spleen lymphocytes were cultured with different
concentrations of LPS in a flat-bottomed 96 well microtiter
plate for 48 hrs at 37°C. Then 0.5 uCi H-thymidine was
introduced into each well and incubated for 6 hrs. Finally the
cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. Data given are the
means+ S.D. of triplicate determinations. Similar results were
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CELLS P.ER WELL( xlO)
Fig. 3 Cell concentration dependence of the basal 3H-thymidine
incorporation
Various cell concentrations of rat spleen lymphocytes were
cultured in a flat-bottomed 96 well microtiter plate for 48 hrs
at 37°C. Then 0.5 uCi 3H-thymidine was introduced into each well
and incubated for 6 hrs. Finally the cells were harvested and the
radioactivity incorporated was determined by liquid scintillation
counting, Data given are the means_+ S.D. of triplicate






























CELLS PER WELL( xlO 5)
CELLS PER WELL (x10-5)
Fig. 4 Cell concentration dependence of H-thymidine
incorporation in the presence of con A
Various cell concentrations of rat spleen lymphocytes were
cultured with 1 ugml of con A in a flat-bottomed 96 well
microtiter plate for 48 hrs at 37°C. Then 0.5 uCi JH-thymidine
was introduced into each well and incubated for 6 hrs. Finally
the cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. Data given are the
means± S.D. of triplicate determinations. Similar results were
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Fig. 5 Cell concentration dependence of thymidine
incorporation in the presence of LPS
Various cell concentrations of rat spleen lymphocytes were
cultured with 10 ugml of LPS in the well of a flat-bottomed 96
well microtiter plate for 48 hrs at 37°C. Then 0.5 uCi H-
thymidine was introduced into each well and incubated for 6 hrs.
Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting.
Data given are the means_+ S.D. of triplicate determinations.
Similar results were obtained in 2 separate experiments.
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3.1.3 Time Dependence of 3 H-Thymidine Incorporation
To examine whether 3I-I-thymidine incorporation by rat spleen
lymphocytes was different at different time points during the 72
hour incubation period, the cultures were pulse-labelled with 3H-
thymidine for 6 hours at different time points. As shown in Fig.
6, the basal 3H-thymidine incorporation was very stable
throughout the 72 hour incubation period except for an initial
drop after ,he first 12 hours.
To study the optimal time point for the mitogens to exert
their mitogenic effects on the rat spleen lymphocytes, similar
pulse labelling experiments were repeated in the presence of con
A and LPS. If one defines the mitogenic index as the ratio of 3H-
thymidine incorporation in the presence of mitogen to that in its
absence, it is apparent from Fig. 7 and 8 that the optimal
mitogenic effect for both con A and LPS can be obtained after 48
hours of mitogen treatment. Consequently, the spleen lymphocytes
were pulsed with 3 F-1-thymidine at 48 hours and harvested at 54
hours in all subsequent experiments.
3. 2 Effects of Adrenergic and Cholinergic Drugs on 3H-Thymidine
Incorporation































0-6 12-18 24-30 48-54 72-78
PULSE 'LABELLING PERIOD( hr)
Fig. 6 Time dependence of 3H-thymidine incorporation in the
absence of mitogens
10 rat spleen lymphocytes were cultured in a flat-bottomed 96
well microtiter plate for 0, 12, 24, 48 or 72 hrs at 37°C. Then
0.5 uCi 3H-thymidine was introduced into each well and incubated
for 6 hrs. After which, the cells were harvested and the
radioactivity incorporated was determined by liquid scintillation
counting. Data given are the means_+ S.D. of triplicate




















0-6 12-18 24-30 48-54 72-78
PULSE LABELLING PERIOD( hr)
Fig. 7 Time dependence of 3H-thymidine incorporation in the
presence of con A
3 x 103 rat spleen lymphocytes were cultured with 1 ugml con A
in a flat-bottomed 96 well microliter plate for 0, 12, 24, 48 or
72 hrs at 37°C. Then 0.5 uCi 3H-thymidine was introduced into
each well and incubated for 6 hrs. After which, the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. Data given are the means_+ S. D. of
triplicate determinations. Similar results were obtained in 2
separate experiments. Mitogenic index is the ratio of H-
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PULSE LABELLING PERIOD( hr)
Fig. 8 Time dependence of H-thymidine incorporation in the
presence of LPS
3 X 10 rat spleen lymphocytes were cultured with 10 ugml LPS
in a flat-bottomed 96 well microtiter plate for 0, 12, 24, 48 or
72 hrs at 37°C. Then 0.5 uCi T1-thymidine was introduced into
each well and incubated for 6 hrs. After which, the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. Data given are the means_+ S.D. of
triplicate determinations. Similar results were obtained in 2
separate experiments. Mitogenic index is the ratio of H-
thymidine incorporation in the presence of mitogen to that in its
absence.
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All three adrenergic drugs tested, namely, isoproterenol,
norepinephrine and epinephrine, shoied a dose-dependent
suppression of the basal (Fig. 9), con A-induced (Fig. 10) and
LPS-induced (Fig. 11) 3 H-thymidine incorporation into the rat',
spleen lymphocytes. IC50 (concentration of drugs which gives 50%
inhibition) of ,he drugs were between 10 and 100 uM.
Carbachol did not seem to have any significant effect on the
con A-induced 3IH-'Lhymidine incorporation (Fig. 13) but exhibited
a slight but significant inhibition of the basal incorporation at
100 uM and 1 mM on the basal incorporation (Fig. 12). Significant
inhibition of LPS-induced 3Hi-thymidine incorporation was also
observed at 10 uM, 100 uM and 1 mM of carbachol (Fig. 14).
3.2.2 Cytotoxicity of Adrenergric Drugs
The viability of spleen lymphocytes in the presence of 100
UN isoproterenol, nbrepinephrine or epinephrine was not
significantly different from that of the control. However, in the
presence of 1 mM of these adrenergic drugs, the cell viability
was significantly lower than that of the control (Table 1). In
other words, 100 uM of these drugs were non-cytotoxic whereas
they were toxic at 1 mM Consequently, 100 uM of the adrenergic
drugs was employed in all subsequent experiments in order to
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CONCENTRATION OF DRUGS( M)
3
Fig. 9 Action of adrenergic drugs on the basal H-thymidine
incorporation
10 rat spleen lymphocytes were cultured with different
concentrations of isoproterenol()-, norepinephrine (A) or
epinephrine(•) in a flat-bottomed 96 well microtiter plate for
48 hrs at 37°C. Then 0.5 uCi 3H-thymidine was introduced into
each well and incubated for 6 hrs. Finally the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. The typical amount of JH-thymidine
incorporated in the absence of drugs was 5»000 cpm. Data given
are the means+ S.D. of triplicate determinations. Similar






























11 i i i
-5 -5 -4 -4
n 1n 7vin in vin
CONCENTRATION OF DRUGS( M)
Fig. 10 Action of adrenergic drugs on the con A-induced 3H-
Fhmi Hi ni= i nrnrnnrat.i on
3 x 105 rat spleen lymphocytes were cultured with different
concentrations of isoproterenol(), norepinephrine (A) or
epinephrine(•) in the presence of 1 ugml con A in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37°C. Then 0.5
uCi 3 H-thymidine was introduced into each well and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting. The
typical amount of 3H-thymidine incorporated in the absence was
50,000 cpm. Data given are the means+_ S.D. of triplicate
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CONCENTRATION OF DRUGS( M)
Fig. 11 Action of adrenergic drugs on the LPS-induced 3 H-
thymidine incorporation
3 x 105 rat spleen iymphocytes were cultured with different
concentrations of isoproterenol(;, norepinephrine( A) or
epinephrine(•) in the presence of 10 ugml LPS in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37 C. Then 0.5
uCi H-thymidine was introduced into each well and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting. The
typical amount of 3H-thymidine incorporated in the absence of
drugs was 10,000 cpm. Data given are the means_+ S.D. of
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CONCENTRATION OF CARBACHOL( M)
Fig. 12 Action of carbachol on the basal 3 H-thymidine
incorporation
10 rat spleen lymphocytes were cultured with different
concentrations of carbachol in a flat-bottomed 96 well microtiter
plate for 48 hrs at 37°C. Then 0.5 uCi 3 H-thymidine was
introduced into each well and incubated for 6 hrs. Finally the
cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. The typical amount
of 3h_thymidine incorporated in the absence of drugs was 5,000
cpm. Data given are the means_+ S.D. of triplicate
determinations. Similar results were obtained in 2 separate
experiments.
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CONCENTRATION OF CARBACHOL( M)
Fig. 13 Action of carbachol on the con A-induced 3H-thymidine
incorporation
3 x 105 rat spleen lymphocytes were cultured with different,
concentrations of carbachol in the presence of 1 ugml con A in
a flat-bottomed 96 well microtiter plate for 48 hrs at 37°C. Then
0.5 uCi 3 H-thymidine was introduced into each well and incubated
for 6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting. The
typical amount of 3 H-thymidine incorporated in the absence of
drugs was 50,000 cpm. Data given are the means_+ S.D. of
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Fig. 14 Action of carbachol on the LPS-induced 3H-thymidine
incorporation
3 x 10 rat spleen lymphocytes were cultured with different
concentrations of carbachol in the presence of 10 ugml LPS in a
flat-bottomed 96 well microtiter plate for 48 hrs at 37 °C. Then
0.5 uCi 3h-thymidine was introduced into each well and incubated
for 6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting. The
typical amount of H-thymidine incorporated in the absence of
drugs was 10,000 cpm. Data given are the means_+ S.D. of
triplicate determinations. Similar results were obtained in 2
separate experiments.
Significantly different from the control (P0.05).
Table 1 Effect of adrenergic drugs on the percentage
viability of rat spleen lymphocytes
% viability
in the presence of
100 uMa 1 mMb
C I N E I N E
no mitogen 61+6 60+2 58+2 62+1 37+5 37+1 49+1
1 ugml con A 49+1 43+11 49+5 47+6 28+5 15+3 26+3
10 ugml LPS 44_+8 46+1 49+4 43+5 29+3 21+1 22+8
Data given are the means_+ S.D. of triplicate determinations.
Similar results were obtained in two separate experiments.
Not significantly different from control (P0.05)
Significantly lower than control (P:0.Q5).
Abbreviations: C, control; I, isoproterenol; N, norepinephrine;
E, epinephrine.
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3.2.3 Time Dependence of Adrenergic Drug Action on 3 H-Thyrnidine
Incorporation
The suppressive action of isoproterenol, norepinephrine or
epinephrine on the basal,con A-induced and LPS-induced 3H-
thyrnidine incorporation was most potent when the drugs were added
at the beginning of the incubation period, the suppressive
effects sere progressively lower when the drugs were added at
later tirre points (Fig. 15-17).
3.3 Effects of cAMP on 3H-Thymidine Incorporation
3.3.1 Effects of cAMP Elevating Drugs on 3 H-Thymidine
Incorporation
Dibutyryl cAMP is a cAM' derivative. Theophylline and IBMX
are cAMP phosphodiesterase inhibitors. Addition of these drugs
into the lymphocyte cultures will mimic the action of or lead to
an increase in cAMP level in the lymphocytes. All three drugs
showed a dose-dependent suppression of the basal, con A-induced
and LPS-induced 3H-thymidine incorporation suggesting that cAMP
was inhibitory to lymphocyte proliferation (Fig. 18-20).
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Fig. 15 Time dependence of adrenergic drug action on the basal
3H-thymidine incorporation
10 6 rat spleen lymphocytes were exposed to 100 uM
isoproterenol(), norepinephrine (A) or epinephrine(•) in a
flat-bottomed 96 well microtiter plate after 0, 12, 24, 36 or 48
hrs of incubation at 37°C. At 48 hrs of incubation, 0.5 uCi 3H-
thymidine was introduced into each well and incubated for 6 hrs.
Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting. The
typical amount of '3H-thymidine incorporated in the absence of
drugs was 5,000 cpm. Data given are the means_+ S. D. of
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Fig. 16 Time dependence of adrenergic drug action on the con A-
induced 3 H -thymidine incorporation
3 x 105 rat spleen lymphocytes were exposed to 100 uM
isoproterenol(), norepinephrine (A) or epinephrine(•) in the
presence of 1 ugml con A in a flat-bottomed 96 well microtiter
plate after 0, 12, 24, 36 or 48 hrs of incubation at 37°C. At 48
hrs of incubation, 0.5 uCi 3H-thymidine was introduced into each
well and incubated for 6 hrs. Finally the cells were harvested
and the radioactivity incorporated was determined by liquid
scintillation counting. The typical amount of 3H-thymidine
incorporated in the absence of drugs was 50,000 cpm. Data given
are the means_+ S.D. of triplicate determinations. Similar
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Fig. 17 Time dependence of adrenergic drug action on the LPS-
induced 3H -thymidine incorporation
3 x 105 rat spleen lymphocytes were exposed to 100 uM
isoproterenol(), norepinephrine (A) or epinephrine(•) in the
presence of 10 ugml LPS in a flat-bottomed 96 well microtiter
plate after 0, 12, 24, 36 or 48 hrs of incubation at 37°C. At 48
hrs of incubation, 0.5 uCi 3H-thymidine was introduced into each
well and incubated for 6 hrs. Finally the cells were harvested
and the radioactivity incorporated was determined by liquid
scintillation counting. The typical amount of 3H-thymidine
incorporated in the absence of drugs was 10,000 cpm. Data given
are the means_+ S.D. of triplicate determinations. Similar
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Fig. 18 Effect of cAMP elevating drugs on the basal 3H-thymidine
incorporation
10 rat spleen lymphocytes were cultured with different
concentrations of dibutyryl cAMP(•) theophylline() or IBMX
( A) in a flat-bottomed 96 well microtiter plate for 48 hrs at
37 °C. Then 0.5 uCi 3 H-thymidine was introduced into each well
and incubated for 6 hrs. Finally the cells were harvested and the
radioactivity incorporated was determined by liquid scintillation
counting. The typical amount of 3 H-thymidine incorporated in
the absence of drugs was 5,000 cpm. Data given are the means_+
S.D. of triplicate determinations. Similar results were obtained
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Fig. 19 Effect of cAMP elevating drugs on the con A-induced 3H-
thymidine incorporation
3 x 10 rat spleen lymphocytes were cultured with different
concentrations of dibutyryl cAMP(•), theophylline(,) or IBMX
(a) in the presence of 1 ugml con A in a flat-bottomed 96 well
microti tier plate for 48 hrs at 37 °C. Then 0.5 uCi 3H-thymidine
was introduced into each well and incubated for 6 hrs. Finally
the cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. The typical amount
of 3 H-thymidine incorporated in the absence of drugs was
50,000 cpm. Data given are the means jf S.D. of triplicate
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Fig. 20 Effect of cAMP elevating drugs on the LPS-induced 3H-
thymidine incorporation
c:
3 x 10 rat spleen lynphocytes were cultured with different
concentrations of dibutyryl cAMP(•), theophylline() or IBMX
(A) in the presence of 10 ugml LPS in a flat-bottomed 96 well
microtiter plate for 48 hrs at 37 °C. Then 0.5 uCi 3H-thymidine
was introduced into each well and incubated for 6 hrs. Finally
the cells were harvested and the radioactivity incorporated was
determined by liquid scintillation counting. The typical amount
of H-thymidine incorporated in the absence of drugs was
10,000 cpm. Data given are the means_+ S.D. of triplicate
determinations. Similar results were obtained in 2 separate
experiments.
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The viability of spleen lymphocytes in the presence of 500
Lill and 1 mM of dibutyryl cAIVP or theophylline as well as 30 uM
and 100 t1 IBMX was not significantly different from that of the
control (Table 2). In other words, these drugs were able to
suppress 3 H-thymidine incorporation without actually killing the
lymphocytes.
3.3.3 clic AIIP Accumulation stimulated Isoproterenol
Within 2 min of incubation, isoproterenol (1 uM) was able to
increase the cAMP level in the rat spleen lymphocytes from less
than 1 pmoles/106 cells to more than 6 pmoles/106 cells in the
presence of 10 mM theophylline. This rise in cAMP level reached a
plateau between 2 and 3 min of incubation (Fig. 21).
Isoproterenol elicited a dose-dependent increase in cAMP level
(Fig. 22). The maximal response occurred at about 1 d.-1
isoproterenol.
3.3:4 Time Dependence of cAMP Elevating Drugs on 3H-Thymidine
Incorporation
As shown in Fig. 23 to 25, the inhibitory action of
dibutyryl CAMP, theophylline and IBMX on the basal, the con A-
induced and the LPS-induced 3H-thymidine incorporation was most
potent when the drugs were added at the beginning of the
Table 2 Effect of dibutyryl cAMP, theophylline and IBEX on




C 100uM 1 mT'l 100uM 1mM 30uM 100uM
no mitogen 50+3 50+4 54+5 50+6 55+7 55+7 53+3
1 ugml con A 30+4 28+6 28+4 31+4 30+6 29+7 243
10 ugml LPS 25+.5 22+1 29+1 26+3 26+6 21+5 23+6
Data given are the means_+ S.D. of triplicate determinations.
Similar results were obtained in tvo separate experiments.
All test groups were not significantly different from control
(P0.05).
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Fig. 21 Time dependence of cAMP accumulation by isoproterenol
stimulation
Rat spleen lymphocytes were incubated in the presence of 1 uM
isoproterenol and 10 mM theophylline at 37°C for various time
periods. The reaction mixture was then boiled for 4 min to stop
the reaction. Precipitates formed were centrifuged at 10,000 x g
for 15 min at room temperature. 50 ul of the supernatant was used
for cAMP determination. Data given are the means_+ S.D. of
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Fig. 22 Dose response curve of isoproterenol on cAMP accumulatior
Rat spleen lymphocytes were incubated at 37°C for 1 min in the
presence of different concentrations of isoproterenol and 10 mM
theophylline. The reaction mixture was then boiled for 4 min to
stop the reaction. Precipitates formed were centrifuged at 10,000
x g for 15 min at room temperature. 50 ul of the supernatant was
used for cAMP determination. Data given are the means_+ S.D. of
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Fig. 23 Time dependence of cAMP elevating durgs on the basal 3H-
thvmidine incorporation
10 rat spleen lymphocytes were cultured with 100 uM IBMX (A), 1
mM theophylline() or 1 mM dibutyryl cAMP(•) in a flat-bottomed
96 well microtiter plate for 0, 12, 24, 36 or 48 hrs at 37 °C. At
48 hrs of incubation 0.5 uCi 3H-thymidine was introduced into
each well and incubated for 6 hrs. Finally the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. Data given are the means_+ S.D.
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Fig. 24 Time dependence of cAMP elevating drugs on the con A-
induced 3H-thymidine incorporation
3 x 105 rat spleen lymphocytes were cultured with 100 uM IBMX
(A), 1 mM theophylline() or 1 mM dibutyryl cAMP(•) in the
presence of 1 ugml con A in a flat-bottomed 96 well microtiter
plate for 0, 12, 24, 36 or 48 hrs at 37 °C. At 48 hrs of
incubation, 0.5 uCi 3H-thymidine was introduced into each vell
and incubated for 6 hrs. Finally the cells were harvested and the
radioactivity incorporated was determined by liquid scintillation
counting. Data given are the means S.D. of triplicate
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Fig. 25 Time dependence of cAMP elevating drugs on the LPS-
induced H-thymidine incorporation
3 x 10 rat spleen lymphocytes vere cultured with 100 uM IBMX
( A), 1 mM theophylline() or 1 mM dibutyryl cAMP(•) in the
presence of 10 ugml LPS in a flat-bottomed 96 well microtiter
plate for 0, 12, 24, 36 or 48 hrs at 37 °C. At 48 hrs of
incubation, 0.5 uCi 3H-thymidine was introduced into each well
and incubated for 6 hrs. Finally the cells were harvested and the
radioactivity incorporated was determined by liquid scintillation
counting. Data given are the means+_ S.D. of triplicate
determinations. Similar results were obtained in 2 separate
experiments.
incubation period. The inhibition became less and less as the
drugs were added at later time points.
3-4 Effects of A23187 and PMA on 3H-Thymidine Incorporation
3 4.1 Effects of A23187 on H-Thymidine Incorporation
A23187 is a calcium ionophore which provides ion channels on
the plasma membrane and allows extracellular calcium ion to get
into the cell dcwn its concentration gradient. At a lower cell
concentration (3 x 105 cells per well), A23187 had a biphasic
effect on the H-thymidine incorporation (Fig. 26). It optimally
stimulated the 3H-thymidine incorporation at 1 uM. However, when
the concentration was raised to 3 uM, it actually inhibited the
basal incorporation of the label. A similar biphasic dose-
response pattern was observed at a higher cell concentration (10
cells per well). However, the optimal stimulation occurred at 300
nM, and A23187 became inhibitory at 1 uM.
3.4.2 Effects of PMA on 3 H-Thymidine Incorporation
Phorbol 12-myristate 13-acetate (PMA) is an activator of
protein kinase 0. It stimulated the basal H—thymidine
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Fig. 26 Effect of A23187 on the basal 3H-thymidine incorporation
3 x 105(•) or 106 (O) rat spleen lymphocytes were cultured with
different concentrations of A23187 in a flat-bottomed 96 well
microtiter plate for 48 hrs at 37°C. Then 0.5 uCi 3h-thymidine
vas introduced into each well and incubated for 6 hrs. Finally
the cells were harvested and the radioactivity incorporated was
by liquid scintillation counting. Data given are the
means+ S.D. of triplicate determinations. Similar results were
obtained in 2 separate experiments.
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dependent manner (Fig. 27). In the presence of 1 ug/rnl con A,
however, PMA was inhibitory (Fig. 28). Complete inhibit ion
occurred at 10 ug/ml of PMA. In the presence of 10 ug/ml LPS, PPM
was stimulatory at 10 ng/ml. In a typical experiment (Table 3),
the stimulation of 3F1-thymidine incorporation produced by LPS (10
ug/ml) alone and PMA (10 ng/ml) alone were 6615 cpm and 1476 cpm
respectively. However, when the two drugs were added together to
the lymphocytes, the stimulation was 19417 cpm. There was thus an
increase of 11326 cpm which cannot be accounted for by simple
addition effects of the 2 drugs. This indicates that LPS and PMA
could act synergistically to stimulate DNA synthesis. The
stimulation, however, decreased as the concentration of PMA was
increased further. Complete inhibition, again, occurred at 10
ug/ml (Fig. 29).
3.4.3 Effects of Various Drugs on the PMA-Induced 3H-Thymidine
Incorporation
The presence of 100 uM of isoproterenol, norepinephrine,
epinephrine, dibutyryl cAIP, IBMX and 1mM of theophylline were
able to inhibit the PMA-induced 3H-thymidine incorporation (Fig.
30). They were also inhibitory on the combined action of LPS (10
ug/ml) and PMA (10 ng/ml) (Fig. 32). However, when PMA was added
together with con A in the lymphocyte culture, only the last
three drugs were able to inhibit further the diminished response.
The adrenergic drugs seemed to have lost their ability in
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Fig. 27 Effect of PMA on the basal 3H-thymidine incorporation
106 rat spleen lymphocytes were cultured with different
concentrations of PMA in a flat-bottomed 96 well microtiter plate
for 48 hrs at 37°C. Then 0.5 uCi 3H-thymidine was introduced into
each well and incubated for 6 hrs. Finally the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. Data given are the means_+ S.D. of
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Fig. 28 Effect of PMA on the con A-induced 3H-thymidine
i nr.Arnnra ti on
3 x 10 rat spleen lymphocytes were cultured with different
concentrations of PMA in the presence of 1 ugml con A in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37°C. Then 0.5
uCi 3H-thymidine was introduced into each well and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated vas determined by licjuid scintillation counting.
Data given are the means_+ S.D. of triplicate determinations.
Similar results were obtained in 2 separate experiments.
















Data given are the means_+ S.D. of triplicate determinations.
Similar results were obtained in two separate experiments.
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Fifi. 29 Effect of PMA on the LPS-induced 3 H-thymidine
• i
3 x 105 rat spleen lymphocytes were cultured with different
concentrations of PMA in the presence of 10 ugml LPS in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37 C. Then 0.5
uCi 3H-thymidine was introduced into each vell and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting.
Oats given are the means_+ S.D. of triplicate determinations.
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Fig. 30 Effect of various drugs on the basal 3 H-thymidine
incorporation in the presence of PMA
106 rat spleen lymphocytes were cultured with various drugs as
indicated above in a flat-bottomed 96 well microtiter plate for
48 hrs at 37°C. Then 0.5 uCi 3h-thymidine was introduced into
each well and incubated for 6 hrs. Finally the cells were
harvested and the radioactivity incorporated was determined by
liquid scintillation counting. Data given are the means_+ S.D. of
triplicate determinations. The 100% control corresponded to
5,000 cpm in a typical experiment. Similar results were obtained
in 2 separate experiments.
Abbreviations: I, 100 uM isoproterenol; N, 100 uM norepinephrine;
E, 100 uM epinephrine; D, 100 uM dibutyryl cAMP; T, 1 mM
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Fig. 31 Effect of various drugs on 3H-thymidine incorporation in
the presence of con A and PMA
3 X 10 rat spleen lymphocytes were cultured with various drugs
as indicated above in the presence of 1 ugml con A in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37°C. Then 0.5
uCi 3H-thymidine was introduced into each well and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting.
Data given are the means_+ S.D. of triplicate determinations. The
100% control corresponded to 50,000 cpm in a typical experiment.
Similar results were obtained in 2 separate experiments.
Abbreviations: I, 100 uM isoproterenol; N, 100 uM norepinephrine;
E, 1-00 uM epinephrine; D, 100 uM dibutyryl cAMP; T, 1 mM
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Fig. 32 Effect of various drugs on 3H-thymidine incorporation in
the presence of LPS and PMA
3 X 105 rat spleen lymphocytes were cultured with various drugs
as indicated above in the presence of 10 ugml LPS in a flat-
bottomed 96 well microtiter plate for 48 hrs at 37°C. Then 0.5
uCi 3H-thymidine was introduced into each well and incubated for
6 hrs. Finally the cells were harvested and the radioactivity
incorporated was determined by liquid scintillation counting.
Data given are the means_+ S.D. of triplicate determinations. The
100% control corresponded to 10,000 cpm in a typical experiment.
Similar results vere obtained in 2 separate experiments.
Abbreviations: I, 100 uM isoproterenol; N, 100 uM norepinephrine;
E, 100 lM epinephrine; D, 100 uM dibutyryl cAMP; T, 1 rnM
theophylline; X, 100 uM IBMX.
(Fig. 31).
3.5 Adrenergic and Cholinergic Receptor Binding on The Rat Spleer
Lymphocytes
3H-Dihydroalprenolol (3H-DHA) is a beta-adrenergic receptor
antagonist which binds to the beta receptor with high affinity.
When 3H-DHA (1 nM) was incubated with 4.0 x 107 rat spleen
lymphocyte, the total binding was about 4300 cpm and the non¬
specific binding in the presence of 1 mM propanolol was about 300
cpm. There were about 2.1 fmole specific 3H-DHA binding sites per
10 cells (Table 4). Propanolol was able to displace the specific
H-DHA binding in a dose-dependent manner with an IC of 1 uM,
indicating the existence of beta-adrenergic receptors on the rat
spleen lymphocytes (Fig. 33). On the other hand, little or no
alpha adrenergic receptors could be detected using 3H-para-
arninoclonidine (3H-PAC) and 3H-VB4101 (Table 4) as radioligands
for alpha2 and alpha]L adrenergic receptors respectively.
1-Quinuclidinyl-(phenyl-4-3H)-benzilate( 3H-QNB) is a
muscarinic cholinergic receptor antagonist which binds
specifically to the muscarinic cholinergic receptors. When 3H-QNB
(2 nM) was incubated with 4.0 x 10 rat spleen lymphocytes, the
total binding was about 2000 cpm and the non—specific binding in
the presence of 1 mM atropine was abouc j500 cpm. Io wao estimated
that there were about 1.3 fmole specific 3H-QNB binding sites per







3 H— 0I1A 2.2+0.02 0.1+0.01 2.1+0.02
H-WB4101 1.1+0.45 1.2j+0.17 not detectable
3H-PAC 0.3+0.02 0.3±0.02 not detectable
3H-QNB 1.5+0.04 0.2+0.00 1.3+0.04
Data given are the means_+ S.D. of duplicate determinations,
Similar results were obtained in two separate experiments.





cpm is the counts per minute obtained by liquid scintillation counting.
10 is used to represent the binding sites at 10 cells.
0.4 is the counting efficiency.
2.2 x 1012 is the disintegrations per min for 1 Ci.
4 x 107 is the cell number at which the assay was performed.
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Fig. 33 Displacement curve of 3H-DHA binding on rat spleen
4.0 x 10 7 rat spleen lymphocytes were incubated in the presence
of 3 H-DHA (1 nM) and various concentrations of propanolol for 30
min at 37°C. At the end of the incubation, the cell suspension
was filtered through Whatman GFB glass fiber filter under
suction. The radioactivity retained on the filter was determined
by liquid scintillation counting. Data given are the means_+ S.D.
of duplicate determinations. Similar results were obtained in 2
separate experiments.
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106 cells (Table 4). Atropine, which is a muscarinic antagonist,
was able to displace the specific 3H-QNB binding in a dose-
dependent manner with an IC50 of 3 uM, indicating the existence
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Fig. 34 Displacement curve of3 H-QNB binding on rat spleen
lymphocytes
4.0 x 107 rat spleen lymphocytes were incubated in the presence
of 3 H-QNB (2 nM) and various concentrations of atropine for 60
min at 37°C. At the end of the incubation, the cell suspension
was filtered through Whatman GFB glass fiber filter under
suction. The radioactivity retained on the filter was determined
by liquid scintillation counting. Data given are the means+ S.D.





4.1 Some Characteristics of The Lymphocyte Culture System
Since lymphocyte proliferation is always accompanied by DNA
replication which incorporates thymidine, it should therefore be
reflected by the amount of 3H-thymidine incorporated in our
experiments. This assay of DNA synthesis is a sensitive one with
a low background because active DNA synthesizing cells are rare
in many lymphocyte populations (Ling and Kay, 1975d) and
thymidine incorporation is confined to cells in the S phase
(Cooper et al., 1963). Moreover, the trapping of free 3H-
thymidine onto the filter paper was negligible. -3H-thymidine was
used instead of 3H-uridine or 3H-leucine because activation of
lymphocytes to RNA and protein synthesis is not necessarily an
indication of lymphocyte proliferation e. g. while a high
proportion of lymphocytes responds to PHA by an increase in RNA
and protein synthesis, only half of the population actually
initiates DNA synthesis (Ling and Kay, 1975d).
In order to avoid antigenic stimulation, one single spleen
was used in every individual experiment. This might, however,
exaggerated the variations in our experiments due to individual
differences. It is fully aware that the spleen lymphocytes used
in the present experiments comprised both T and B lymphocytes,
and there might be the problem of interactions among the
lymphocytes as well as between lymphocytes and other cell types.
Future experiments should also be performed on isolated T and B
lymphocyte populations in order to resolve these possibilities.
89
Con A, instead of PHA which is another commonly used T
lymphocyte mitogen, was used because it is the best characterized
plant lectin, more potent and produces less agglutination and
cell damage (Stobo et al., 1972 Ling and Kay, 1975a,1975c). The
dose response curve of con A shown in Fig. 1, therefore,
reflected the response of T lymphocytes to the mitogen. Con A
exhibited an optimal stimulation at 1 ug/ml but at higher
concentrations, the response diminished. This is consistent with
the results of Kaever and Resch (1985) who suggested that the
decreased response was the result of an increase in intracellular
cAMP (see Introduction 1.3.2).
Although LPS is a B lymphocyte mitogen, it stimulates about
only 22% of the total B lymphocyte population in nude murine
spleen cultures (Watson, 1976). The dose response curve of LPS in
Fig. 2 might thus only be that of a B lymphocyte subpopulation.
Nevertheless, LPS was still employed since other common B
lymphocyte mitogens like dextran sulphate and
polyinosinic:polycytidylic acid elicited less than 10% of the
cells to respond (Watson, 1976).
An important parameter that needs to be characterized in a
culture system is an optimal cell concentration so that neither
the nutrients present nor the metabolites released are limiting
factors to their growth. On the basis of the results presented in
Fig. 4 and 5, a concentration of 3 x 105 cells per well in the
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presence of either con A or LPS which give 30-50% of the maximal
response was chosen. A higher cell concentration, 106 cells per
well, was deliberately used to increase the signal in the absence
of con A or LPS so that the effects of drugs could be observed
more clearly in subsequent experiments.
Both con A and LPS activated spleen lymphocytes showed
maximal mitogenic index after 48 hours of incubation (Fig. 7 and
8) which was consistent with that described by Ling and Kay
(1975d). Forty-eight hours of incubation was thus allowed for the
lymphocytes to enter the S phase before pulse labelling of 3H-
thymidine. At 24 and 72 hours, increased mitogenesis was also
observed indicating a heterogeneity in the periods of cell cycle
among the lymphocytes (see Introduction 1.2.5). Since mitosis and
cytoplasmic division can only occur after the S phase, the
appearance of cell aggregates within 10 hours of incubation in
the presence of con A might simply be due to the agglutinating
property of con A but not cell division.
In the absence of mitogens, the 3 H-thymidine incorporation
was quite stable except an initial drop during the first 12 hours
of incubation. This probably represents a drop in cell viability
plus a completion of the S phase of lymphocytes which had been
activated in vivo before the spleen was removed. In fact, 3H-
thymidine incorporation in the absence of added mitogens has been
suggested to be due to a continuation of proliferation activity
when they are freshly prepared, and a response to stimulants in
the medium like fetal calf serum (Ling and Kay, 1975c).
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Therefore, 3H-thymidine incorporation which occurred in the
absence of mitogens should better be referred to as "spontaneous"
incorporation rather than "resting" incorporation.
From the above experiments, I have established the optimal
conditions for examining 3H-thymidine incorporation in cultured
rat spleen lymphocytes, being, 3 x 105 cells per well in the
presence of either 1 ug/ml con A or 10 ug/ml LPS or 10 6 cells per
well in the absence of mitogens, to be incubated at 37°C for 48
hours followed by 6 hours pulse labelling of 3H-thymidine.
4.2 Effects of Adrenergic and Cholinergic Drugs on 3H-Thymidine
Incorporation
All three adrenergic drugs tested were able to suppress 3H-
thymidine incorporation into the rat spleen lymphocytes (Fig. 9).
It appeared that both T and B lymphocytes were susceptible as
both con A and LPS stimulated 3H-thymidine incorporation were
also inhibited (Fig. 10 and 11). Viability test by trypan blue
dye exclusion indicated that these adrenergic drugs were not
cytotoxic at 100 uM (Table 1). Thus, their effects on 3H-
thymidine incorporation cannot be accounted for by a nonspecific
killing of lymphocytes. On the other hand, it is debatable
whether these suppressive effects are physiologically or
pharmacologically relevant. The apparent high concentration of
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adrenergic drugs required for inhibiting 3H-thymidine
incorporation may be related to the metabolism and/or degradation
of the drugs during the 48 hours of incubation at 37 °C. In
fact, the adrenergic drugs underwent chemical oxidation and
changed from a colorless solution to dark brown color after
incubated at 37 °C for 48 hours with or without the presence of
lymphocytes.
According to the in vitro observations presented here, the
inhibitory' effect of norepinephrine on the production of antibody
forming cells (Besedovsky et al., 1981) may be due to its
inhibition of lymphocyte proliferation.
When the spleen lymphocytes were exposed to the adrenergic
drugs at later times after incubation, they were less affected
with respect to the 3H-thymidine incorporation (Fig.15 to 17).
The drugs were almost ineffective when added at 48 hours at
which the lymphocytes were in the S phase (see Discussion 4.1).
This is in agreement with Whitfield and co-workers (1985) who
suggest that cells are most sensitive to signals in their
environment during the prereplicative period to avoid the
disruption and death which would result from being stopped in the
middle of the S phase or mitosis. On the other hand, it can also
be inferred that only a long period of exposure of lymphocytes to
the adrenergic drugs could result in an appreciable suppression.
In order to take such a possibility into consideration, after the
addition of the adrenergic drugs at different time points, the
drugs should be washed away subsequently so that the length of
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drug exposure are the same.
To examine the existence of adrenergic receptors on the
lymphocyte surface by radioreceptor assays, possible interference
from erythrocytes which contain adrenergic receptors (Charness et
al., 1976) has to be avoided. Erythrocytes in the spleen cell
preparation were first lysed with Tris-buffered ammonium chloride
solution and removed by washing twice in RPMI 1640 medium.
Lefkowitz (1975) suggested that 1 uM propanolol is able to
fill all beta-adrenergic receptor sites even in the presence of
high concentrations of radioligand. As shown in Fig. 33, it is
interesting to note that propanolol as high as 100 uM was
required to displace presumably all the specific 3H-DHA binding
on the rat spleen lymphocytes. The reason for the low potency of
propanolol to displace 3H-DHA was not understood. Nevertheless,
the radioreceptor binding result supports the existence of beta
adrenergic receptors on rat spleen lymphocytes.
No specific binding of the alphal receptor ligand, 3H-WB4101
,and alpha2 receptor ligand, 3H-PAC could be detected on the rat
spleen lymphocytes. These results support the suggestion that it
is the beta rather than alpha. receptors which are responsible for
the mediation of adrenergic suppression of 3H-thymidine
incorporation in rat spleen lymphocytes.
Besides beta adrenergic receptors, muscarinic cholinergic
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receptors were also detected on the rat spleen lymphocytes (Fig.
34). Muscarinic cholinergic binding sites had been detected on
erythrocytes (Mantione and Hanin, 1980). Their interference was
again eliminated in the present study by the use of the Tris-
buffered ammonium chloride solution. On the other hand, since
intact viable cells were used, 3H-QNB might be taken up and bound
intracellularly (Adem et al., 1986). The muscarinic receptor
number estimated might thus be higher than the actual value.
Gossuin's group (1984) claimed that such problem was not
detectable when 3H-methylscopolamine was used as a ligand. This
makes the use 3H-methylscopolamine more appropriate for labelling
cell surface muscarinic receptors in the future.
Since the two biochemical reactions mediated by muscarinic
cholinergic activation are either a decrease in cAMP level or an
increase in phosphatidylinositol 4',5'-bisphosphate hydrolysis
(Harden et al., 1986), muscarinic cholinergic activation are
expected to stimulate lymphocyte proliferation (see Introduction
1.3 and 1.4, and Discussion 4.3 and 4.4).. In fact, muscarinic
cholinergic activation has been found to stimulate lymphocyte
proliferation (see Introduction 1.1.3 abd 1.1.4). Surprisingly,
both the basal and LPS-induced 3H-thymidine incorporation were
slightly inhibited by carbachol (Fig. 12 and 14) while the con A-
induced one was unaffected (Fig. 13). None of these exhibited a
stimulatory response. Therefore, it is interesting to find out if
the inhibitory effects of carbachol are mediated by mechanisms
other than muscarinic cholinergic activation, say, a nicotinic
activation.
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4.3 Effect of cAMP on 3H-Thymidine Incorporation
To examine the role of cAMP in the inhibition of 3 H-
thymidine incorporation in both T and B lymphocytes by adrenergic
drugs, the effects of dibutyryl cAMP, theophylline and IBMX were
examined. Dibutyryl cAMP is a cAMP derivative and is used instead
of cAMP because it can pass into the cell readily while it is
more difficult for the charged cAMP to enter the cell.
Furthermore, cAMP is metabolized more rapidly in lymphocyte
culture (MacManus et al., 1971). Theophylline and IBMX are cAMP
phosphodiesterase inhibitors which can increase the intracellular
cAMP level by inhibiting its degradation.
Fig. 20 to 22 showed that these cAMP elevating drugs were
able to suppress the basal, con A-induced and LPS-induced 3 H-
thymidine incorporation indicating that cAMP was indeed an
inhibitory signal to lymphocyte proliferation. The fact that IBNLX
was more potent than theophylline in suppressing 3 H-thymidine
incorporation as well as inhibiting cAMP phosphodiesterase
suggest that cAMP accumulation was responsible for the
suppression. Viability test illustrated that the suppression of
3H-thymidine incorporation by dibutyryl cAMP, theophylline and
IBMX was not a result of the cy-totoxic effect of these agents
(Table 3.3-1).
Since fetal calf serum might be responsible for the Masai
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3 H- thymidine incorporation (Ling and Kay, 1975c), cAMP might
therefore be an inhibitor to the signal elicited by the serum
factors (Fig. 20). Consistent with this argument is that when
calf serum was depleted in 3T3 cell cultures, cAMP level rose
and the cells became quiescent (Seifert and Paul, 1972). The
suppression caused by the cAMP elevating agents in con A-induced
3H-thymidine incorporation (Fig. 21) implied that cAMP was an
inhibitory signal in T lymphocyte proliferation. In fact, it has
been pointed out that the diminished proliferation caused by high
con A concentrations was due to an increase in intracellular cAMP
(Kaever and Resch, 1985). LPS-induced 3 H-thymidine incorporation
has been suggested to occur as a result of inhibition of
adenylate cyclase and thus a drop in the cAMP level (Jakway and
DeFranco, 1986). It was therefore no surprise that cAhP elevating
agents used here were able to inhibit the LPS action (Fig. 22).
Since beta adrenergic receptors had been demonstrated to be
present on the lymphocyte surface (see Discussion 4.2), it was
expected that beta adrenergic agonists were able to elicit cAMP
production. Indeed, 1 uM isoproterenol, a beta agonist, was
found to stimulate cAMP accumulation in rat spleen lymphocytes in
the presence of a cAM phosphodiesterase inhibitor, theophylline
(Fig. 18 and 19). However, it was also found that the cAMP
accumulation began to level off at 1 uM isoproterenol which was
almost useless in inhibiting 3H-thymidine incorporation (see Fig.
9-11). Such inconsistency may be accounted for by the assay
system used in measuring cAMP production. For instance,
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theophylline used might not effectively inhibit the
phosphodiesterase activity so that high intracellular cAMP levels
stimulated by high concentrations of isoproterenol could not be
reached. Lysis of erythrocytes by the Tris-buffered ammonium
chloride solution might perturb the integrity of lymphocytes.
Incubation in the absence of energy supply might as well be a
cause of the under-estimation of the EC5 0 (concentration of drug
which gives 50% excitation). Consequently, the use of more
potent phosphodiesterase inhibitor, removal of erythrocytes by
Ficoll gradient, and cAMP accumulation assay performed in RPMI
1640 medium without FCS which might inhibit adenylate cyclase,
might perhaps yield a higher EC5 0 in eliciting cAMP accumulation.
Moreover, incubation of the adrenergic drugs at 37°C for 48 hours
might cause a certain degree of degradation. Thus, an apparently
higher concentration was required to produce a suppression (see
Discussion 4.2).
In spite of all these complications, it was still possible
that adrenergic drugs, through activation of beta receptors on
the lymphocyte surface, elicit cAMP accumulation which in turn
suppress lymphocyte proliferation.
In the previous section, it was found that the potency of
the adrenergic drugs dropped as they were added at later time
points. One could argue that as the lymphocytes progressed along
the cell cycle, the beta adrenergic receptors and its
transduction mechanism may be progressively shut down so that
adrenergic drugs in the extracellular space could not induce cAMP
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accumulation inside the lymphocytes. Hence, the lymphocytes might
become unresponsive. However, from Fig. 23 to 25, the cAMP
elevating drugs showed a similar although not identical time
dependence response in comparison to that of the adrenergic
drugs. This would not only argue against the above statement but
also suggest that the effect of adrenergic drugs may indeed be
mediated through cAMP accumulation.
In this section, the inhibitory effect of cAMP was studied
by using cAMP elevating agents. In order to further evaluate such
an inhibitory effect, drugs lowering intracellular cAMP level
should be explored to see if they could really stimulate 3 H-
thymidine incorporation in the rat spleen lymphocytes.
4.4 Effects of A23187 and PMA on 3 H-Thymidine Incorporation
It was shown in Fig. 26 that A23187 was able to stimulate
3H-thymidine incorporation in rat lymphocytes. Since A23187 is a
calcium ionophore, the increase in 3H-thymidine incorporation was
most likely due to an increase in intracellular calcium level.
There were at least three possible explanations for such an
activation. Firstly, calcium ion alone might be sufficient to
elicit lymphocyte proliferation. Secondly, the elevated calcium
level might activate protein kinase C directly. Thirdly, the
elevated calcium level might first activate a calcium dependent
protease which in turn can cause a proteolytic activation of
protein kinase C (Isakov et al., 1986 Murry et al., 1987). In
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the last two possibilities, calcium may act synergistically with
protein kinase C to trigger off DNA synthesis in the rat spleen
lymphocytes. In fact, such a synergistic action had been observed
in lymphocytes (Mastro and Smith, 1983). The first possibility
can be differentiated from the second and third by use of
polymyxin B which is a protein kinase C inhibitor. Polymyxin B
should not be able to inhibit the calcium ionophore action in the
first case but would inhibit in the second and third cases.
Similarly, the use of protease inhibitor e. g. leupeptin
(Pontremoli et al., 1986) might help to differentiate the second
and third possibilities.
Another interesting phenomenon to observe was that A23187
exhibited different dose responses at the two different cell
concentrations employed (Fig. 26). Such a phenomenon may possibly
involve helper and suppressor factors secreted by the spleen
lymphocytes. The logic is that a direct effect of A23187 could
occur regardless of the cell concentration. However, only at a
high enough cell concentration could the secreted soluble
mediators accumulate to a high enough concentration to exert
their action. At the low cell concentration (3 x 105 cells per
well), 300 nM A23187• was not able to stimulate 3 H-thymidine
incorporation. However, at the high cell concentration (10 6 cells
per well), a stimulatory effect was observed. Therefore, 300 nM
A23187 might not be able to activate lymphocyte proliferation
directly but could activate helper T lymphocytes to secrete
grovith factors whose effect could be observed only at a high cell
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concentration. When the A23187 concentration was raised to 1 uM,
it stimulated DNA synthesis at the low cell concentration
probably indicating a direct activation. However, at 1 UM A23187,
a suppression was observed at the high cell concentration. This
probably indicated the activation of suppressor T lymphocytes
whose effect could be observed only at a high cell concentration.
At 3 uM A23187, 3H-thymidine incorporation in both low and high
cell concentrations was suppressed. This might be due to too high
an intracellular calcium level or suppression from activated
suppressor T lymphocytes.
Consequently, calcium seemed to be effective in activating
both helper and suppressor T lymphocytes to secrete their
products besides directly stimulating lympholcyte proliferation.
Moreover, suppressor factors probably were able to inhibit the
action of calcium in lymphocytes.
Like DG, phorbol myristate acetate (PMA) is able to activate
protein kinase C by increasing its affinity for calcium ion.
Protein kinase C can then phosphorylate the Na+/H +exchanger to
trigger off mitogenesis (Bell, 1986 Isakov et al., 1986). It was
therefore no surprise that PMA could stimulate the basal (Fig.
27)3 H-thymidine incorporation. However, PMA was found to inhibit
the con A-induced 3H-thymidine incorporation (Fig. 28). Since
con A by itself can activate PIP2 hydrolysis and thus protein
kinase C activity (Sugiura and Waku, 1984), the addition of PMA
might cause an overstimulation of protein kinase C activity and
thus that of the Na+/H+ exchanger. A very high intracellular pH
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and Na+ might thus be responsible for the decreased 3H-thymidine
incorporation. In the presence of LPS, PMA could stimulate 3
H-
thymidine incorporation at low concentrations but inhibit at high
concentrations (Fig. 29). The stimulation might be due to
activation of protein kinase C while the inhibition might result
from overactivation of Na+/H+ exchanger from protein kinase C.
The use of ami loride which can inhibit the Na+ /H+ exchanger
(Rozengurt, 1986) may help to test such a hypothesis by
eliminating the suppression if the Na /H+ exchanger was really
the cause. However, such an inhibition was not observed in the
basal 3H-thymidine incorporation. This was again possibly due to
the use of a higher cell concentration (106 cells per well) at
which helper factors released by PMA activation might accumulate
to a certain level enough for stimulating proliferation.
Bijsterbosch and Klaus (1986) have shown that at high non-
mitogenic concentration of con A, neither the PIP2 hydrolysis nor
the calcium ion level were decreased in comparison to those at
mitogenic con A concentration. Kaever and Resch (1985) suggested
that the diminished mitogenesis at high con A concentration was
due to an increase in cAMP. Therefore, the inhibitory action of
cAMP on lymphocyte proliferation is unlikely to be the result of
an inhibition of PIP2 hydrolysis and calcium mobilization. In
fact, from Fig. 30 to 32, it could be seen that dibutyryl cAMP,
theophylline and IBMX were able to inhibit 3 H-thymidine
incorporation in the presence of PMA. This implies that cAMP can
antagonize the action of protein kinase C in triggering
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mitogenesis. The molecular events leading to DNA synthesis can
be categorized into two major classes: the regulatory signals
and obligatory events (Rozengurt, 1986). Regulatory signals of a
given growth factor can be bypassed through the action of other
regulatory factors whereas obligatory events must take place
before l.)NA synthesis can start. Therefore cAMP might inhibit the
action of protein kinase C by inhibiting: 1) the protein kinase
C directly; 2) some regulatory signal(s) which act
synergistically with protein kinase C to trigger off DNA
synthesis or 3) the obligatory events in DNA synthesis.
So far, it was demonstrated that LPS and PMA could increase
3 H-thymidine incorporation by their own. In addition, when these
two drugs were added together in the lymphocyte culture, the
stimulatory response was higher than the sum of the responses
caused by each individual drug (Table 4.1). In other words, PMA
and LPS could act synergistically in rat spleen lymphocyte
proliferation. The signal mediated by LPS has been suggested to
be a lowering in cAMP level (Jakway and DeFranco, 1986) while
that by PMA is an increase in protein kinase C activity. It is
possible that cAMP could inhibit directly the protein kinase C
activity. A lowering in cAMP level might thus act synergistically
with PMA to activated the protein kinase C. Alternatively, it is
possible that cAMP and protein kinase C might be acting in an
opposite manner on some common targets in the lymphocytes. In
fact, a tyrosine specific kinase has been reported to be
inhibited by the cAMP-dependent protein kinase A and stimulated
by protein kinase C (Hirata et al., 1984). Activation of this
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tyrosine specific kinase may play a key role in lymphocyte
mi togenesis.
Since adrenergic drugs were able to produce cAMP through
beta adrenergic receptors on the lymphocyte surface, they could
inhibit the basal and LPS-induced 3H-thymidine incorporation in
the presence of PMA (Fig. 30 and 32). However, when PMA was added
together with con A in the lymphocyte culture, no inhibition
could be observed (Fig. 31). This indicated some kind of
unresponsiveness of the lymphocytes to the adrenergic drugs. It
should not be due to an unresponsiveness to cAMP because
dibutyryl cAMP and the phosphodiesterase inhibitors were still
inhibitory. Instead, the signal transduction mechanism might have
been turned off. Whether PMA acted on the beta adrenergic
receptor, guanine nucleotide binding protein or the adenylate
cyclase remains to be elucidated. This phenomenon was observed
only in the presence of both con A and PMA. Perhaps, only in the
presence of both PMA and con A, which can also activate protein
kinase C, could the protein kinase C gain a high enough activity
to turn down the beta adrenergic transduction mechanism. On the
other hand, interleukin 2 produced by con A activation (Mills et
al., 1986), may co-operate with PMA in the desensitization of




Adrenergic drugs have been shown to cause a non-cytotoxic
inhibition on the proliferation of rat spleen lymphocytes. The
existence of beta adrenergic receptor binding and the cAN P
production in response to isoproterenol suggest that such a
suppression is mediated through cAMP. In fact, cAMP is shown to
be inhibitory to lymphocyte proliferation by using dibutyryl cAMP
and cAMP phosphodiesterase inhibitors.
Both calcium ionophore and phorbol myristate acetate (PMA),
activator of protein kinase C, are able to stimulate 3H-thymidine
incorporation. This suggests that calcium and protein kinase C
are activators of rat lymphocyte proliferation. Since an elevated
intracellular calcium level and protein kinase C activity are the
consequences of phosphatidylinositol 4,5-bisphosphate (PIP2)
hydrolysis, PIP2 signalling mechanism probably exists in the rat
lymphocytes.
Adrenergic drugs, dibutyryl cAMP and cAMP phosphodiesterase
inhibitors can inhibit the action of PMA. Moreover, LPS, which
has been suggested to lower cAMP level, can synergize with PMA in
triggering mitogenesis. Therefore, activation of protein kinase
C, some synergistic mechanism(s) or the obligatory events in DNA
synthesis are susceptible to cAMP inhibition. Furthermore, cAMP
may. antagonize the action of protein kinase C on some common
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target(s). A -tyrosine specific kinase in lymphocytes, in fact,
can be stimulated by protein kinase C but inhibited by protein
kinase A. On the other hand, activation of the protein kinase C
under certain circumstances may down regulate the adrenergic
signal transduction mechanism. This is reflected by the
unresponsiveness of lymphocytes to adrenergic drugs in the
presence of both PMA and con A when dibutyryl cAMP and the cAMP
phosphodiesterase inhibitors are still inhibitory.
In conclusion, both the beta adrenergic receptor linked
adenylate cyclase system and the PIP2 signalling transduction
mechanism presumably exist in rat spleen lymphocytes. Activation
of the former pathway leads to a decrease while activation of the
latter causes an increase in lymphocyte proliferation. These two
pathways thus appear to be antagonistic with each other.
Moreover, cAMP has been found to inhibit the action PMA which
activates protein kinase C to trigger off mitogenesis.
Conversely, activation of protein kinase C may, under certain
conditions, down regulate the beta adrenergic signal transduction
mechanism. These observations suggest that there are strong
interactions between these two pathways. It is hoped that with an
understanding of the exact nature of these fundamental regulatory
mechanisms and their interactions, one can find ways to
manipulate the immune responses and cure some very difficult
diseases as cancer (probably with depressed immune responses),
acquired immunodeficiency syndrome (AIDS) (depressed immune
responses), autoimmune diseases and organ transplantation
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